Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 7
Author(s): Craig S. Atwood
Affiliation:
Export Options
About this article
Cite this article as:
Atwood S. Craig, Meet Our Editorial Board Member, Current Neuropharmacology 2019; 17 (7) . https://dx.doi.org/10.2174/1570159X1707190521092957
DOI https://dx.doi.org/10.2174/1570159X1707190521092957 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
16
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Meet Our Editorial Board Member
Current Alzheimer Research Mean Platelet Volume During Ischemic Stroke is a Potential Pro-inflammatory Biomarker in the Acute Phase and During Neurorehabilitation Not Directly Linked to Clinical Outcome
Current Neurovascular Research Lobeline Docking on AChBP and Nicotinic Receptors: Discriminating Importance of the Pocket Geometry and of the Ligand Configuration
Letters in Drug Design & Discovery Gut Permeability and Microbiota in Parkinson’s Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways
Current Pharmaceutical Design Highly Selective MEK Inhibitors
Current Enzyme Inhibition Osteogenic Differentiation Factors of Multipotent Mesenchymal Stromal Cells in the Current Understanding
Current Pharmaceutical Design Calcium Channel Mutations in Cardiac Arrhythmia Syndromes
Current Molecular Pharmacology Meet Our Section Editor
Current Drug Discovery Technologies Bradykinin Receptors in Ischemic Injury
Current Neurovascular Research Peroxisome Proliferator-Activated Receptor (PPAR) Agonists as Promising New Medications for Drug Addiction: Preclinical Evidence
Current Drug Targets Recent Updates in the Alzheimer’s Disease Etiopathology and Possible Treatment Approaches: A Narrative Review of Current Clinical Trials
Current Molecular Pharmacology Molecular Imaging Strategies for In Vivo Tracking of MicroRNAs: A Comprehensive Review
Current Medicinal Chemistry Immunosuppressive and Antiviral Treatment of Inflammatory Cardiomyopathy
Recent Patents on Cardiovascular Drug Discovery Selective Dopamine D4 Receptor Antagonists: Review ofStructure-Activity Relationships
Current Medicinal Chemistry - Central Nervous System Agents Removing Protein Aggregates: The Role of Proteolysis in Neurodegeneration
Current Medicinal Chemistry Toxicities by Herbal Medicines with Emphasis to Traditional Chinese Medicine
Current Drug Metabolism High Dose Immunoglobulin (IVIG) May Reduce the Incidence of Langerhans Cell Histiocytosis (LCH)-Associated Central Nervous System Involvement
CNS & Neurological Disorders - Drug Targets T Cell-based Therapies for Atherosclerosis
Current Pharmaceutical Design Synthesis of Polymer-Embedded Metal, Semimetal, or Sulfide Clusters by Thermolysis of Mercaptide Molecules Dissolved in Polymers
Recent Patents on Materials Science Roles of CLR/RAMP Receptor Signaling in Reproduction and Development
Current Protein & Peptide Science